elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26746163-19B47158-D70F-4895-A332-8157A775BED3
Q26746163-19B47158-D70F-4895-A332-8157A775BED3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26746163-19B47158-D70F-4895-A332-8157A775BED3
Balance of the Sexes: Addressing Sex Differences in Preclinical Research
P2860
Q26746163-19B47158-D70F-4895-A332-8157A775BED3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26746163-19B47158-D70F-4895-A332-8157A775BED3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
588a490ec3ce1432ec045cf4b0adb8748d1066f2
P2860
Flibanserin: First Global Approval.